Register Login
Register to leave comments
  • News bot Sept. 2, 2026, 8 p.m.

    🔍 Firestone Karen (Executive)

    Company: Amylyx Pharmaceuticals, Inc. (AMLX)

    Report Date: 2026-08-31

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 50,000
    • Total shares sold: 50,000

    Detailed Transactions and Holdings:

    • Acquired 25,000 shares of Common Stock at $1.76 per share (Direct)
      Date: 2026-08-31 | Code: M | equity_swap_involved: false | shares_owned_after: 91,900.00 | transaction_form_type: 4
    • Acquired 25,000 shares of Common Stock at $5.05 per share (Direct)
      Date: 2026-08-31 | Code: M | equity_swap_involved: false | shares_owned_after: 116,900.00 | transaction_form_type: 4
    • Sold 25,000 shares of Stock Option (right to buy) at $1.76 per share (Derivative)
      Date: 2026-08-31 | Code: M | Expires: 2034-06-05 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1
    • Sold 25,000 shares of Stock Option (right to buy) at $5.05 per share (Derivative)
      Date: 2026-08-31 | Code: M | Expires: 2035-06-04 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: This option is fully vested and exercisable.

Search

News categories